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Background: While arthrodesis is the standard treatment of a severely arthritic ankle joint, total ankle arthroplasty
has become a popular alternative. This review provides clinical outcomes and complications of both interventions
in patients with rheumatoid arthritis.
Methods: Studies were obtained from Pubmed, Embase and Web of Science (January 1980 – June 2011) and
additional manual search. Inclusion criteria: original clinical study, > 5 rheumatoid arthritis (population), internal
fixation arthrodesis or three-component mobile bearing prosthesis (intervention), ankle scoring system (outcome).
The clinical outcome score, complication- and failure rates were extracted and the methodological quality of the
studies was analysed.
Results: 17 observational studies of 868 citations were included. The effect size concerning total ankle arthroplasty
ranged between 1.9 and 6.0, for arthrodesis the effect sizes were 4.0 and 4.7. Reoperation due to implant failure or
reoperation due to non-union, was 11% and 12% for respectively total ankle arthroplasty and arthrodesis. The
methodological quality of the studies was low (mean 6.4 out of a maximum of 14 points) and was lower for
arthrodesis (mean 4.8) as compared to arthroplasty (mean 7.8) (p = 0.04).
Conclusions: 17 observational and no (randomized) controlled clinical trials are published on the effectiveness of
arthroplasty or arthrodesis of the ankle in rheumatoid arthritis. Regardless of the methodological limitations it can
be concluded that both interventions show clinical improvement and in line with current literature neither
procedure is superior to the other.
Keywords: Rheumatoid arthritis, Ankle joint / talocrural joint, Three component mobile bearing prosthesis / third
generation total ankle implant, Ankle arthrodesis / ankle fusion, Clinical outcome scoreBackground
Ankle arthritis usually occurs in the later stages of
rheumatoid arthritis (RA). In end stage ankle arthritis
surgical management is often necessary, consisting of ei-
ther arthrodesis or arthroplasty.
Arthrodesis (or ankle fusion) has long been considered
to be the gold standard. The advantage of arthrodesis is a
potential gain of walking ability due to relief of pain and
decrease of deformity. However the loss of ankle motion,
imposes stress on other joints and may, especially in RA* Correspondence: H.J.L.van_der_Heide@lumc.nl
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distribution, and reproduction in any mediumpatients, increase degenerative lesions in the mid- and
forefoot [1].
Total ankle arthroplasty (TAA) preserves ankle range
of motion (ROM), thereby compromising gait pattern to
a lesser extent and imposing less stress on other joints
[2,3]. Despite the potential advantages total ankle arthro-
plasty may not be the best treatment option for all
patients as an implant requires adequate bone support
and there is a risk of reoperation due to loosening [4].
The effectiveness of both interventions with mixed
indications has been described in three systematic re-
views, including second- and third generation implants
and arthrodesis [5-7].Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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Haddad et al., including thirty-nine original studies,
showed that 73% (95% confidence interval (95% CI):
61–84), of all patients experienced a good result [5].
Concerning total ankle arthroplasty this meta-analysis,
including ten primary studies, evaluated only second
generation implants, and concluded that 78% (95% CI:
62–95) showed good results [5]. With respect to third
generation implants Stengel et al., included ten studies
and presented a weighted average improvement of 45.2
points (maximum score: 100 points) [6]. Gougoulias
et al., reviewing thirteen studies and focusing on clinical
failure- and survival rates of both second and third
generation implants, showed 9.8% (95% CI 3.1– 16.5)
implants failure after 5 years [7].
For both ankle arthrodesis and total ankle arthroplasty
there has been no systematic review which included only
RA patients or reported specifically the results of this
patient group. Furthermore the systematic review, in-
cluding arthrodesis studies, focused only on the clinical
outcome scores whereas, complication types- and rates
were not evaluated [5]. For outcome studies it is important
to include and evaluate each diagnostic group separately,
as factors as morbidity status are important to determine
success [3]. Data of Stengel et al. showed that RA patients,
overall have lower scores using functional scoring systems
than patients with a single joint problem [6].
Therefore the aim of this study is to systematically
review the literature regarding the effectiveness and safety
of ankle arthrodesis and total ankle arthroplasty in RA pa-
tients. To enable comparisons among studies this review
focuses on the standard surgical methods, i.e. isolated fu-
sion of the talocrural joint by internal fixation methods
and arthroplasty with third generation implant designs.
Methods
Search strategy
An electronic database search was performed from
January 1, 1980 until June 14, 2011 by one author (JvH) in
cooperation with a trained medical librarian. For the
PubMed, Embase and Web of Science database the follow-
ing search strategies were used:
Pubmed algorithm
 Ankle joint prosthesis OR arthroplasty OR
arthrodesis OR internal fixator rheumatoid arthritis
 Search string for joint: ankle[MeSH Terms] OR
ankle[All Fields] OR ankle joint[MeSH Terms]
 Search string for intervention: arthroplasty,
replacement[MeSH Terms] OR arthroplasty[All
Fields] OR Joint Prosthesis[Mesh] OR Joint
Prosthesis[all fields] OR Joint Prostheses[all fields]
OR replacement[all fields] OR arthrodesis[MeSH
Terms] OR arthrodesis[All Fields] OR arthrodeses[All Fields] OR Internal Fixators[Mesh] OR Internal
Fixator[all fields] OR Internal Fixators[all fields] OR
fusion[all fields]
 Search string for diagnosis: arthritis, rheumatoid
[MeSH Terms] OR rheumatoid[All Fields] AND
arthritis[All Fields]
Embase algorithm
 (Ankle/ or ankle.mp.) AND (exp Arthroplasty/ OR
arthroplasty.mp. OR joint prosthes*.mp. or Joint
Prosthesis/ OR replacement.mp. OR exp
arthrodesis/ OR arthrodes*.mp. OR internal fixator*.
mp. or Internal Fixator/)
Web of Science algorithm
 (rheumatoid arthritis.mp. or Rheumatoid Arthritis/)
Regarding the limited reviewed literature concerning
this topic, a Cochrane database search was not performed.
To search for potential additional studies the electronic
database search was supplemented by a manual check of
references of recent reviews and primary full text articles
identified with the search strategy, as described above.
Selection of articles
All titles, abstracts and selected full text articles were
screened by two authors independently (JvH and HvdH).
The review sought randomized controlled trials (RCTs),
controlled clinical trials and observational studies in
which only RA patients were described or in which data
from RA patients could be extracted from the general
data, and were written in English. Articles published
before 1980 were excluded.
Titles and abstract were screened using three general
criteria:
 Original clinical study (no reviews or case reports)
 The intervention(s) evaluated was arthrodesis, total
ankle arthroplasty or both
 The efficacy of interventions was tested
In case of a potentially relevant title and abstract full
text articles were examined using the aforementioned
inclusion criteria plus the following criteria:
 Studies that reported on at least five RA patients
with end-staged rheumatic ankle(s) were included
(the cut-off point of 5 was chosen as there are very
few studies including large numbers of RA patients).
 The intervention concerned internal fixation
arthrodesis of the talocrural joint or arthroplasty
with a third generation, three-component mobile
bearing prosthesis. If studies presented the outcome
of a combination of internal and external fixation
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in arthroplasty, data derived from internal fixation
or third generation implants could be extracted
separately.
 The clinical outcome had to be evaluated by using
an ankle scoring system, designed for evaluating
surgical interventions for ankle problems, including
the Kofoed [8], Amercian Orthopaedic Foot and
Ankle Society (AOFAS) ankle- and hindfoot score
[9], Foot Functional Index (FFI) [10] and Mazur
score [11]. All scoring systems use somewhat similar
items as pain, function, range of motion (ROM), and
deformity and all have a domain of 100 points [12].
The outcome had to be measured at least once
postoperatively.
Exclusion criterion:
 Studies on the effectiveness of arthrodesis after a
failed total ankle arthroplasty were excluded.
Data extraction
The study characteristics and clinical outcomes were
extracted from the selected full-text articles. For con-
tinuous data, preferably the mean, range and standard
deviation (SD) were extracted. If not presented in the
study, the mean, range and SD data were calculated
whenever possible.
Study characteristics included:
a. Year of publication, time period in which patients
were examined, average duration of follow up
(years), number of RA patients included in the
study, percentage of RA patients in the total
included patient population and gender distribution.
Clinical outcomes included:
a. Type of ankle scoring system, response rate (the total
number of RA patients evaluated divided by the
number of RA patients which were included) and
postoperative and, if available, preoperative ankle
scores (out of 100 points). Comparison between the
various scoring systems is based on the overall
outcome score, as individual items as pain, function
and alignment were often not available. To enable
comparison between Foot Functional Index (FFI)
with other scoring systems, the FFI score was
inverted by subtracting the score from 100. As an
optimal clinical outcome, measured with the FFI is
represented as 0.
b. Frequencies of common complications after ankle
surgery: peri- and postoperative fractures and
infection.c. Failure rates: proportion of patients undergoing
reoperation due to non-union in arthrodesis
or implant removal in arthroplasty followed
by implantation of new component(s)
or fusion.
Quality assessment
As a systematic review can be of great value in evidence
based medicine, it is important that data, upon which
the review is based, are reliable and obtained within a
sound methodological design. As a gold standard for in-
ternal and external validity evaluation of observational
intervention studies does not exists, the authors (JvH,
HvdH and TVV) comprehended a user-friendly seven
item rating system composed of a quality checklist for
intervention studies and diagnostic tests [13,14], shown
in Table 1. This quality appraisal system generally agrees
with other appraisal tools upon most important, well-
known, flaws as selection- and observation bias and
confounding [15,16]. However with this system, discrim-
ination is possible between the reporting- and methodo-
logical quality. To allocate the evaluation criteria to the
four most important elements for conducting evidence:
study design, subjects (patients), outcome and analysis,
this tool can elucidate the flaws and strengths of the
included studies.
Two authors (JvH and HvdH) independently assessed
the methodological quality of each study included in this
review. Each item received 0, 1 or 2 points (descriptors
Table 1), so the maximum score of 14 points reflecting
studies with a good methodological quality. Discrepan-
cies were examined by a third observer (TVV) inde-
pendently and consensus between the three authors was
reached. As one of the raters is also the author of one of
the included articles (HvdH), his study was also scored
blinded by the third reviewer (TVV).
The GRADE criteria were used to describe the overall
quality of evidence and strength of recommendations of
this study.
Data- and statistical analysis
Due to absence of preoperative scores, incomplete mea-
sures of variability, heterogeneity of the patient popula-
tions and variety among outcome scoring systems,
formal pooling and subsequently a comprehensive statis-
tical analysis was not possible. Therefore, descriptive
statistical analyses were used. Results are expressed as
mean and standard deviation (SD). Statistical analysis
was performed using SPSS (IBM SPSS Statistics for
Windows, Version 20.0).
For studies in which the pre- and postoperative clinical
score were available we calculated the effect size by sub-
tracting the pre-operative score from the postoperative
score and divide this number by the standard deviation
Table 1 Descriptors of methodological quality assessment
Evaluation criteria Score Descriptors
Study design Patient evaluation on clinical
relevant time points (3)
2 Patients were evaluated with the same criteria at more than one
clinical relevant time point (pre- and post-operatively).
1 Patients were evaluated at more than one time point (but the
above criteria were not fulfilled).
0 Patients were evaluated at only one point in time.
Evaluation outcome measures (8) 2 Outcome measures were administered by an evaluator who was
blind to treatment or self-report was considered as provided by
an independent person.
1 Evaluators were not blinded, but were not involved in treatment
or self-report was administered by treatment providers.
0 Outcome measures were obtained by unblended treatment providers.
Subject Eligibility criteria (10) 2 Inclusion and exclusion criteria were defined and designed to yield
a study group generalizable to clinical situation.
1 Some available inclusion and exclusion information regarding included
patients, but information prevents to generalize study results to a
specific population.
0 No information on inclusion and exclusion criteria and limited
patients descriptors.
Response rate (12) 2 90% or more of the patients enrolled or eligible for study were
evaluated for outcomes.
1 More than 70% of the patients eligible for study or enrolled were
evaluated for outcomes.
0 Less than 70% of patients eligible for study or enrolled were evaluated.
Outcome Outcome definitions (16) 2 Primary outcome measure, which represented important clinical
outcomes and appropriate psychometric properties (reliability, validity,
responsiveness).
1 Primary outcome measure was evident, but was insufficient in either
its clinical relevance or its psychometric properties.
0 Primary outcome was irrelevant or methodologically unsupported.
Analysis Statistical analysis (21) 2 Authors conveyed both statistical significance and size of treatment
effect. Indicated by p-values, confidence intervals, effect sizes, or other
similar methods.
1 Statistical significance of described means and p-values, but no
confidence intervals/effect sizes.
0 Descriptive, statistical information was not reported.
Data collection (22) 2 Complete data collection or a strategy for handling missing data was
documented or a specific analysis was conducted to determine the
impact of missing data.
1 Missing data was not an apparent issue but no strategy for handling
missing data was described.
0 Missing data may have been an issue and no strategy for missing data was
documented.
*number between parentheses refers to descriptor of the methodological quality assessment system by Macdermid et al. [13].
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tween the two different observers were compared with
an intraclass correlation coefficient (ICC). The methodo-
logical scores between the two different treatment op-
tions were compared with a Student t-test. Correlation
between methodological scores, impact factor of the
journal and study size was calculated using a Spearman
correlation coefficient.Results
Search and selection of articles
The initial electronic databases search yielded a total of
868 titles. The process by which the final selection of ar-
ticles was made is visualized in Figure 1. After excluding
duplicates, articles not written in English and non-
original clinical studies, 369 potentially relevant titles
and abstracts were screened for intervention type

























Figure 1 The article selection process.
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tion, finally 108 full text articles were examined. Consen-
sus was reached by both reviewers (JvH and HvdH) on
17 full text articles.
Description of included studies
Table 2 lists the characteristics of the studies incorpo-
rated in this review. Eight articles evaluated arthrodesis
and nine reported the outcome of total ankle arthro-
plasty. The selected papers were published between 1989
and 2009.
The 17 included studies were performed by 14 differ-
ent centres from Italy, Japan, The Netherlands, Sweden,
United Kingdom and The United States. The studies
were carried out between 1977 and 2004. The mean fol-
low up time varied from 1.6 to 8.3 years. For arthrodesis
the mean follow up period was 3.8 years, and 4.5 yearsfor arthroplasty. Also the number of included RA pa-
tients showed variety (n = 5 to 76). In total, the 17 stud-
ies included 145 RA patients with talocrural arthrodesis
and 260 RA patients with third generation total ankle
prosthesis.
Methodological quality
The methodical quality of the 17 included studies was
assessed with the seven item rating system (Table 1). The
intraclass correlation coefficient (ICC) between the two re-
viewers (JvH and HvdH) was 0.84 (95% CI 0.61-0.94).
As depicted in Table 3, the mean score of the arthro-
plasty studies was 7.8 (SD 2.2), which was substantially
higher than 4.8 (SD 1.3) for the fusion studies (p = 0.04)
(maximum score = 14). The correlation coefficients be-
tween the methodological quality score and the impact
factor of the journal was 0.7 (p = 0.004) and for the
Table 2 Demographic information of included studies
Author Centre Year Recruitment period Follow up (yrs.) n included
RA patients




Mean Range or SD Mean Range
or SD
Total Ankle Arthroplasty (TAA)
van der Heide et al. Radboud University, Nijmegen Medical Centre,
The Netherlands
2009 1996 – 2004 2.7 1-9 54 55 27-82 19% STAR & BP
Schutte et al. Maartenskliniek, Nijmegen, The Netherlands 2008 1999-2004 2.3 1-5.6 29 57 37-81 34% STAR
Nelissen et al.* Leiden University Medical Centre, Leiden,
The Netherlands
2006 2001-2003 2.0 SD: 0,4 15 61 SD 8,6 20% BP
San Giovanni et al. UHZ Sports Medicine Institute, Coral Gables, Florida 2006 1990-1997 8.3 5-12.2 23 61 28-79 9% BP
Doets et al. Slotervaart Hospital, Amsterdam, The Netherlands 2006 1988-1999 7.6 0.4-16.3 76 58 27-81 82% LCS & BP
Carlsson et al. Malmö University Hospital, Malmö, Sweden 2005 - 4.6 4-5 5 66 53-83 40% STAR
Bonnin et al. Clinique Sainte Anne Lumière, Lyon, France 2004 1997-2000 2.9 2-5.7 29 54 28-77 38% SALTO
Anderson et al. Malmö University Hospital, Malmö, Sweden 2003 1993-1999 4.3 3-6.6 22 61 27-75 33% STAR
Wood et al. Wrightington Hospital NHS Trust, Wigan,
United Kingdom
2000 - 5.4 5-6 7 63 36-76 17% STAR
Mean 4.5 59.5 32%
Total 260
Arthrodesis
Anderson et al. Malmö University Hospital, Malmö, Sweden 2005 1991-2002 7.0 2-12 51 56 24-76 17% Percutaneous & open
Kennedy et al. Hospital for special surgery, New York, New York 2003 1992-1996 3.8 2,1-6,3 20 56 31-81 24% Open
Shinomiya et al. School of Medicine University, Tokushima Japan 2003 1986-1996 - - 17 52 σ 7,8 12% -
De Palma et al. Università di Ancona, Ancona, Italy 2000 1994-1995 3.0 2-5 7 48 35-64 0% Arthroscopic
Lauge-Pedersen et al. Lund University Hospital, Lund Sweden 1998 1993-1997 2.3 0,3-4,4 10 66 45-80 40% Percutaneous
Stranks et al. Queen Alexandra Hospital, Portsmouth, United Kingdom 1995 1989-1991 1.6 1-2,5 8 59 51-70 13% Open
Moran et al. Freeman Hospital, Newcastle, United Kingdom 1991 1977-1986 5.0 2-12 26 54 28-80 15% Percutaneous & open
Sowa et al. John Hopkins University, Baltimore, Maryland 1989 1980-1985 4.0 1,1-6,6 6 60 32-77 17% Open
Mean 3.8 56.4 17%
Total 145
* = As the range was not available, the standard deviation is reported.
¯ = information has not been described within the original article.





















Table 3 Methodological quality of included studies

























van der Heide et al. 2009 0 1 0 2 1 1 1 6
Schutte et al. 2008 2 1 1 2 2 1 1 10
Nelissen et al. 2006 2 0 1 2 2 1 1 9
San Giovanni et al. 2006 1 0 1 2 1 1 1 7
Doets et al. 2006 2 0 1 2 2 2 2 11
Carlsson et al. 2005 0 0 1 2 1 0 2 6
Bonnin et al. 2004 2 0 1 2 1 1 1 8
Anderson et al. 2003 2 1 1 2 1 1 1 9
Wood et al. 2000 0 0 0 2 1 0 1 4
Mean 7.8
Arthrodesis
Anderson et al. 2005 0 1 1 0 1 0 2 5
Kennedy et al. 2003 0 0 1 1 1 0 1 4
Shinomiya et al. 2003 0 0 1 2 1 0 0 4
De Palma et al. 2000 2 0 0 2 1 0 1 6
Lauge-Pedersen et al. 1998 0 0 0 2 0 0 1 3
Stranks et al. 1995 0 0 1 2 1 0 1 5
Moran et al. 1991 0 1 1 2 1 0 2 7
Sowa et al. 1989 0 0 1 1 1 0 1 4
Mean 4.8
* = number between parentheses refers to descriptor of the methodological quality assessment system by Macdermid et al. [13].
0 = minimal 1 = intermediate and 2 =maximal score for methodological quality.
Definition of each individual score is presented in Table 1.
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the study was 0.5 (p = 0.04). Furthermore the correl-
ation coefficient of the methodological quality score
and year of publication (before and after 2005) was 0.6
(p = 0.06). So, studies with a high quality score were pub-
lished in higher impact journals, included more patients,
and the quality of the studies increased over time.
We analysed the outcome separately for all studies
with a methodological score of 7 and above, but only
one study in the fusion group had a methodological
score of seven and this study didn’t describe the pre-
operative score so it was not possible to analyse only
the studies with of moderate to good methodological
score.
As all included studies were observational studies they
would be graded as “low evidence” according to the
GRADE classification, furthermore, due to the low qual-
ity it should be downgraded and the grade of evidence
assigned should be “very low”.Effects of intervention
In Table 4 clinical outcome scores are presented. Pre-
operative data and measures of variability were absent in
12 articles [17-28]. This restrains the possibility to meas-
ure the effect size and to compare the preoperative sta-
tus of the two groups. In addition, non-standardized
outcome descriptors such as satisfied (yes/no) or poor
outcome (yes/no) were used in a considerable number of
studies.
The AOFAS, Mazur and Kofoed score were the most
frequently reported evaluation tools. As the range of
motion (ROM) should be zero after a successful fusion,
this is not an appropriate tool for evaluating the success
of arthrodesis. Except for the study of Anderson which
mentioned an adjusted clinical outcome score; the ROM
was not taken into account [11,24]. Shinomiya et al.
explicitly mentioned the inclusion of ROM [20].
As formal pooling was not possible, only a descrip-
tive analysis was performed to present the data. The
Table 4 Primary outcome: total ankle replacement or arthrodesis
























van der Heide et al. 52 0% Kofoed - 73.0 16.0 21-92
Schutte et al. 29 0% FFI 40.0 14.0 66.0 19.0 - 26.0 1.9
29 Kofoed - 69.0 20.0 -
Nelissen et al. 15 0% AOFAS 22.0 9.7 80.0 8.0 - 58.0 6.0
San Giovanni et al. 21 0% AOFAS - 81.0 - 40-92
Doets et al.* 76 0% LCS 36.1 12.5 34-39 81.5 13.1 78-84 45.4 3.6
76 AOFAS 26.5 11.6 24-29 77.7 14.0 75-81 51.2 4.4
76 Kofoed 26.9 13.5 24-30 74.0 14.9 71-77 47.1 3.5
Carlsson et al. 5 0% AOFAS - 82.2 7.2 74-92
Bonnin et al. 29 1% AOFAS - 84.2 14.0 -
Anderson et al.° 22 0% Kofoed 35.0 21-43 71.0 - 21-96 36.0
22 AOFAS - 78.0 - 33-100
22 Mazur - 72.0 - 28-91
Wood et al. 7 Kofoed - 74.0 - -
Mean 31.1 12.9 76.0 14.0 44.0 3.9
Arthrodesis
Anderson et al.¯ 35 2% Mazur max 90 points - 61.3 12.5 23-73
35 AOFAS max 86 points - 64.9 14.8 15-85
Kennedy et al. 17 15% Mazur 24.0 - 2-30 69.0 - 5-83 45.0
17 Moran 28.0 - 2-32 79.0 - 17-89 51.0
Shinomiya et al.+ 17 - JOA score - 66.8 4.1 -
De Palma et al. 7 0% AOFAS 26.7 13.0 14-45 79.0 10.3 67-94 52.3 4.0
Lauge-Pedersen et al. 9 0% Mazur - 63.9 10.8 50-85
9 Moran - 88.8 8.5 73-97
Stranks et al. 8 0% Mazur - 58.3 16.2 32-80
Moran et al. 21 0% Mazur - 61.7 7.7 48-76
Sowa et al. 6 Mazur 16.8 13.6 8-43 80.3 13.1 65-95 63.5 4.7
Mean 23.9 13.3 70.3 10.9 53.0 4.4
* = Post-operative score was after 1 year evaluation.
° = The values are given as the median, with the range in parentheses.
¯ = Both outcome scores are adjusted to different max. score.
+ = Arthrodesis patients served only as control group for reviewed second generation total ankle implant.
Abbreviations: AOFAS American Orthopaedic Foot & Ankle Society, FFI Foot Functional Index, JOA Japanese Orthopaedic Association.
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40.0 points (SD range: 9.7 - 14.0). In the arthrodesis
group this score ranged from 16.8 to 28.0 points (SD
range: 13.0 - 13.6). The postoperative score for total
ankle arthroplasty ranged from 66.0 to 84.2 points
(SD range: 7.2 – 20.0), and for arthrodesis this was
between 58.3 and 88.8 points (SD range: 4.1–16.2).
The effect size could only be determined in 5 studies.
The effect size for an implant ranged from 1.9 to 6.0
and in the arthrodesis group the original studies pre-
sented effect sizes of 4.0 and 4.7.Complications
Table 5 lists the complication- and failure rates per
intervention type. The most frequently reported type of
complication of arthroplasty was a perioperative fracture
(26%). Patients who underwent fusion experienced
mainly wound healing problems (17%). The failure rate
was 11% for arthroplasty and 12% for arthrodesis.
Regarding numbers of complications and failure there
is a wide range among different studies. Doets et al. re-
ported 29% perioperative fractures, as Anderson et al.
did not report any fractures [2,23]. Furthermore studies













Reoperation due to implant removal
(TAA) or non-union (arthrodesis)(n)
TAA
van der Heide et al. 56 29% (16) 5% (3) - 4% (2) 9% (5)
Schutte et al.* 29 - - - - -
Nelissen et al. 15 - 7% (1) 13% (2) - 0%
San Giovanni et al. 31 32% (10) 13% (4) 13% (4) 0% (0) 6% (2)
Doets et al. 93 29% (27) 4% (9) 10% (4) 4% (4) 16% (15)
Carlsson et al.* 5 - - - - 0%
Bonnin et al.* 29 7% (2) - - - 0%
Anderson et al. 28 - 9% (2) - - 24% (6)
Wood et al. 7 14% (1) 14% (1) - - 0%
Total 293 26% (56) 9% (20) 7% (10) 3% (6) 11% (28)
Arthrodesis
Anderson et al. 35 - 9% (3) 3% (1) 3% (1) 14% (5)
Kennedy et al. 20 - 10% (2) - 5% (1) 15% (3)
Shinomiya et al. 17 - - - - -
De Palma et al. 7 0% 0% 0% 0% 0%
Lauge-Pedersen et al. 11 0% 0% 18% (2) 0% 0%
Stranks et al. 8 - - - - 0%
Moran et al. 30 - 40% (12) 7% (2) 10% (3) 20% (6)
Sowa et al. 6 17% (1) 17% (1) 0% 0%
Total 134 0% 17% 7% 6% 12%
* = complications/failure in RA patients was not described.
Type of complication not described or not possible to extract from published data.
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et al. did not report failure. However studies with > 20
patients did [29]. Overall we find heterogeneity in the
amount of complications. Figure 2 visualizes a positive
correlation Rho = 0.73 (p = 0.003) between study size
and number of reported failure rate. When larger
amounts of patients were included, higher failure rates
were reported. Due to publication bias it is possible that
only smaller series with good results were published.
Whereas series with high complication- and, or failure
rates will not be published.
Discussion
Neither randomized controlled trials nor controlled clin-
ical trials are published on the effectiveness of arthro-
plasty or arthrodesis of the ankle in rheumatoid arthritis.
This review included 17 observational studies, all with
low methodological quality. Furthermore due to clinical
heterogeneity, formal pooling was not possible and be-
cause the absence of preoperative scores and measures
of variability, statistical analyses were limited. Theselimitations result in a systematic review with low quality
of evidence according to the GRADE guidelines [30].
Both interventions show a comparable clinical improve-
ment. For arthrodesis the postoperative scores, with a
mean follow up time of 3.8 years, ranged from 58.3 to 88.8
(maximum of 100) and for total ankle arthroplasty with
third generation prostheses, with a mean follow up time of
4.5 years, the scores ranged between 66.0 and 84.2. The
effect sizes for arthrodesis were 4.0 and 4.7, and the effect
size in the implant group ranged between 1.9 and 6.0.
However when interpreting the effect sizes for arthrodesis,
the non-adjustment of clinical outcome score, regarding
the ROM, must be bear in mind. A successful fusion will
obviously result in no range of motion. This could imply
underestimation up to 10%, of the result of arthrodesis.
Moreover the failure rates, in this review characterized as
reoperation due to implant removal in the arthroplasty
group or to non-union in arthrodesis, were similar (11–
12%). Expect for a study by de Palma et al., who included
only 7 patients, we obtained just results of open ankle fu-



















Spearman Rho is 0.73; p=0.003
Figure 2 Correlation between study size and number of
reported failures.
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seems not suitable to correct large deformities which are
often present in RA patients [29,31]. In future research
the value of arthroscopic fusion in this specific patient
group could be investigated.
The clinical outcome for both interventions in RA pa-
tients, presented in this review, is overall consistent with
earlier published results in a mixed population by Stengel
et al. and Gougoulias et al. [6,7]. At moment of writing
only Haddad et al. as well systematically reviewed both
arthroplasty and arthrodesis; however the authors fo-
cused only on the second generation implants. Never-
theless, comparable with our data, they found similar
clinical outcomes for both surgical interventions [5]. To
weigh each intervention, this review also focused on
complication- and failure rates. Concerning arthrodesis
we reported a non-union rate of 12%, which is consist-
ent with earlier presented publications [5,32]. Compli-
cations as deep infections, loosening and fractures after
implant surgery were only evaluated by Stengel et al.
[6]. The failure rates for total arthroplasty were evalu-
ated in two original studies [32,33] and the three afore-
mentioned reviews [5-7]. The peri- and postoperative
complications as superficial and deep infections (resp.
10.8% and 1.6%) are comparable to findings of this review
(resp. 9% and 3%) [6]. Although failure of an implant was
defined as implant removal and not as revision, the failure
rate 11% (range: 0–24%) is also in line with the findings of
Stengel et al., Gougoulias et al. and Saltzman et al.
[6,7,33]. However the failure rate was higher compared to
the second generation implants evaluated by Haddad
et al., who showed revision rate of 7%, but was lower com-
pared to a large observational study published in 2007 l
[5,32]. Unfortunately the authors did not describe the type
and or generation of implants, which hampers to explain
discrepancies between their result and the overall lowrevision rate [5,32]. Soohoo et al. described a moderate re-
vision rate for implants of 9% after one year, but after five
years it was 23% compared to respectively 5% and 11% for
arthrodesis [32]. This implicates that the risk of major re-
vision surgery increases in the long-term. However this re-
view could not demonstrate such a trend, though the
reviewed arthroplasty studies showed a mean mid-term
follow up time of 4.5 years (range: 2.0 - 8.3 years). Never-
theless, regarding the increased popularity of ankle im-
plants, long-term results (> 5 years) and revision rates are
needed.
The strength of this review lies in the assessment of
the methodological quality of included studies. Further-
more we focused on patients with R.A., which is an
unique patient population compared to patients with a
monoarticular problem. Also inclusion of results of the
newer third generation implants has not been exten-
sively described before. An important weakness of this
review is the outcome scoring system. Only studies,
which applied a 100 point ankle scoring scale, were in-
cluded. Scoring systems which provided nominal out-
comes e.g. good and poor were excluded. This was done
to obtain objectified data and to compare, in which ex-
tent this is possible, the different evaluation tools. Not-
withstanding this limitation, the great diversity among
(non-validated) scoring systems i.a. prevented pooling
and therefore this review provides subsequently subopti-
mal evidence.
Regrettably three major issues concerning the included
studies; 1) small study size, 2) clinical heterogeneity and 3)
poor methodological design, restrained us to present a
comprehensive statistical analysis with pooled data.
1) Small study size: 9 out of the 17 included studies
included < 20 patients [17-19,25,28,29,34,35]. The
low failure- and complication rate in small studies
needs to be noted as this could be an indication for
publication bias, which is important as published
studies can have a high impact on daily medical
practice.
2) Clinical heterogeneity: Neither pre-existing
conditions, preoperative functional status e.g. the
health assessment questionnaire (HAQ), nor all
preoperative clinical outcome scores were presented.
This prevented pooling, but might also lead to
selection bias. Furthermore it is important to bear in
mind that a negative and significant correlation
between functional scores and the activity of the
rheumatic disease can explain a low clinical outcome
with similar or even better treatment effects in
patients with a high disease activity [24].
3) Poor methodological design: In the included articles
it concerned paucity of statistical parameters,
heterogeneity in complication and failure
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non-validated and non-uniform outcome scores.
However this review revealed the methodological
quality of included studies no certain cut-off value
was applied as exclusion criterion regarding the
small number of studies (17). Statistical parameters
as the standard deviation, which was absent in 4
studies [19,21,23,24,26] prevented measuring the
effect size.
The heterogeneity in definitions of complication and
failure prevented also comparison. Several authors char-
acterized e.g. failure as revision but also as radiographic
loosening. These different described endpoints raise the
question whether the presented results are consistent
with patients’ satisfaction.
The use of non-validated rating scales as mentioned
before is also a problem, as the outcomes are not stan-
dardized and therefore not reproducible, their use ham-
pers evaluation. Of the 17 included studies only Schutte
et al. applied a validated rating scale, the FFI [36,37].
Furthermore, apart from Anderson et al., authors of the
arthrodesis studies did not describe adjustment of the
functional score to the normal loss of motion after fusion
of the talocrural joint, which makes it a non-uniform scor-
ing system [24]. As not all authors mentioned adjustment,
we could not adjust the maximum score. Therefore, as
stated earlier, the effect size must be interpreted with
awareness of underestimation of successful fusion.
Even when all included studies would have been meth-
odological well designed, indication bias remains a threat
to validity in observational studies. Indication bias is
controlled best by an RCT, however randomization and
control is not always feasible. When two interventions
have different profiles, both patients and surgeons have
a preferable intervention. Strong preferences make re-
cruitment difficult if not impossible [38]. To overcome
the problems with randomization a clinical controlled
trial can be preferable. Moreover as historically most ad-
vances in surgical knowledge have been accepted on the
basis of non-randomized studies [38].
To improve the quality of research in the future, the re-
search proposal should include and evaluate each diagnostic
group separately, as factors as morbidity status are import-
ant to determine success [3]. To make studies comparable,
the same validated rating scale, preferably a patient reported
outcome measure would be valuable [36]. Currently the FFI,
and recently also the Swedish version of the self-reported
foot and ankle score (SEFAS) and the Manchester-Oxford
Foot Questionnaire (MOFXFQ) are validated outcome mea-
sures [36,39,40]. With well-defined cohorts, outcomes, end-
points, exposures, predictors and possible confounders, a
prospective observational study can give important contri-
butions to ankle surgery in rheumatic patients.Conclusions
Currently no controlled clinical trials on the effectiveness
of arthroplasty or arthrodesis of the ankle in rheumatoid
arthritis have been published. Regardless of the methodo-
logical limitations it can be concluded from 17 obser-
vational studies, that both interventions show clinical
improvement. This is in line with current literature that
indicate that no procedure is superior to the other. How-
ever it remains to be established which treatment gives the
best results in longer term. These interventions should
preferably be studied with a randomized controlled trial,
however cohort studies with sound methodological me-
thods could also be of value.
Competing interests
Each author certifies he/she has no commercial associations or non-financial
competing interest that might pose a conflict. The authors did not receive
grants or funding in support for preparation of this manuscript.
Authors’ contributions
JvH & JM Langenhoff (medial librarian) carried out the electronic database
search. Subsequently the selection of articles was performed by JvH & HvdH.
For the quality assessment JvH & HvdH independently scored the included
studies, discrepancies were examined by TVV after which consensus was
reached. Data extraction was carried out by JvH. Statistical analysis was
performed by HvdH. JvH drafted the manuscript. HvdH helped and
commentated on the discussion. All authors read and approved the final
manuscript.
Acknowledgements
We would like to thank JM Langenhoff, medical librarian, Leiden University
Medical Centre, for help with the electronic database search.
Received: 26 November 2012 Accepted: 19 September 2013
Published: 26 October 2013
References
1. Fuchs S, Sandmann C, Skwara A, Chylarecki C: Quality of life 20 years after
arthrodesis of the ankle: a study of adjacent joints. J Bone Joint Surg Br
2003, 85(7):994–998.
2. Doets HC, Brand R, Nelissen RG: Total ankle arthroplasty in inflammatory
joint disease with use of two mobile-bearing designs. J Bone Joint Surg
Am 2006, 88(6):1272–1284.
3. Wood PL, Clough TM, Smith R: The present state of ankle arthroplasty.
Foot Ankle Surg 2008, 14(3):115–119.
4. Wood PL, Crawford LA, Suneja R, Kenyon A: Total ankle replacement for
rheumatoid ankle arthritis. Foot Ankle Clin 2007, 12(3):497–508. vii.
5. Haddad SL, Coetzee JC, Estok R, Fahrbach K, Banel D, Nalysnyk L:
Intermediate and long-term outcomes of total ankle arthroplasty and
ankle arthrodesis: a systematic review of the literature. J Bone Joint Surg
Am 2007, 89(9):1899–1905.
6. Stengel D, Bauwens K, Ekkernkamp A, Cramer J: Efficacy of total ankle
replacement with meniscal-bearing devices: a systematic review and
meta-analysis. Arch Orthop Trauma Surg 2005, 125(2):109–119.
7. Gougoulias N, Khanna A, Maffulli N: How successful are current ankle
replacements?: a systematic review of the literature. Clin Orthop Relat Res
2010, 468(1):199–208.
8. Kofoed H, Sorensen TS: Ankle arthroplasty for rheumatoid arthritis and
osteoarthritis: prospective long-term study of cemented replacements.
J Bone Joint Surg Br 1998, 80(2):328–332.
9. Kitaoka HB, Alexander IJ, Adelaar RS, Nunley JA, Myerson MS, Sanders M:
Clinical rating systems for the ankle-hindfoot, midfoot, hallux, and lesser
toes. Foot Ankle Int 1994, 15(7):349–353.
10. Budiman-Mak E, Conrad KJ, Roach KE: The foot function Index: a measure
of foot pain and disability. J Clin Epidemiol 1991, 44(6):561–570.
11. Mazur JM, Schwartz E, Simon SR: Ankle arthrodesis: long-term follow-up
with gait analysis. J Bone Joint Surg Am 1979, 61(7):964–975.
van Heiningen et al. BMC Musculoskeletal Disorders 2013, 14:306 Page 12 of 12
http://www.biomedcentral.com/1471-2474/14/30612. Naal FD, Impellizzeri FM, Rippstein PF: Which are the most frequently used
outcome instruments in studies on total ankle arthroplasty? Clin Orthop
Relat Res 2010, 468(3):815–826.
13. MacDermid JC: An introduction to evidence-based practice for hand
therapists. J Hand Ther 2004, 17(2):105–117.
14. Shamliyan T, Kane RL, Dickinson S: A systematic review of tools used to assess
the quality of observational studies that examine incidence or prevalence
and risk factors for diseases. J Clin Epidemiol 2010, 63(10):1061–1070.
15. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J: Methodological
index for non-randomized studies (minors): development and validation of
a new instrument. ANZ J Surg 2003, 73(9):712–716.
16. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M,
Altman DG, International Stroke Trial Collaborative G, European Carotid Surgery
Trial Collaborative G: Evaluating non-randomised intervention studies. Health
Technol Assess 2003, iii-x(27):1–173.
17. Moran CG, Pinder IM, Smith SR: Ankle arthrodesis in rheumatoid arthritis:
30 cases followed for 5 years. Acta Orthop Scand 1991, 62(6):538–543.
18. Stranks GJ, Cecil T, Jeffery IT: Anterior ankle arthrodesis with cross-screw
fixation: a dowel graft method used in 20 cases. J Bone Joint Surg Br 1994,
76(6):943–946.
19. Wood PLR, Clough TM, Jari S: Clinical comparison of two total ankle
replacements. Foot Ankle Int 2000, 21(7):546–550.
20. Shinomiya F, Okada M, Hamada Y, Fujimura T, Hamada D: Indications of
total ankle arthroplasty for rheumatoid arthritis: evaluation at 5 years or
more after the operation. Mod Rheumatol 2003, 13(2):153–159.
21. Kennedy JG, Harty JA, Casey K, Jan W, Quinlan WB: Outcome after single
technique ankle arthrodesis in patients with rheumatoid arthritis. Clin
Orthop Relat Res 2003, 412:131–138.
22. Bonnin M, Judet T, Colombier JA, Buscayret F, Graveleau N, Piriou P:
Midterm results of the salto total ankle prosthesis. Clin Orthop Relat Res
2004, 424:6–18.
23. Anderson T, Montgomery F, Carlsson A: Uncemented STAR total ankle
prostheses. J Bone Joint Surg Am 2004, 86(1):103–111.
24. Anderson T, Maxander P, Rydholm U, Besjakov J, Carlsson A: Ankle
arthrodesis by compression screws in rheumatoid arthritis: primary
nonunion in 9/35 patients. Acta orthopaedica 2005, 76(6):884–890.
25. Carlsson A, Markusson P, Sundberg M: Radiostereometric analysis of the
double-coated STAR total ankle prosthesis: a 3–5 year follow-up of 5
cases with rheumatoid arthritis and 5 cases with osteoarthrosis. Acta
orthopaedica 2005, 76(4):573–579.
26. San Giovanni TP, Keblish DJ, Thomas WH, Wilson MG: Eight-year results of
a minimally constrained total ankle arthroplasty. Foot Ankle Int 2006,
27(6):418–426.
27. van der Heide HJ, Schutte B, Louwerens JW, van den Hoogen FH, Malefijt
MC: Total ankle prostheses in rheumatoid arthropathy: outcome in 52
patients followed for 1–9 years. Acta orthopaedica 2009, 80(4):440–444.
28. Lauge-Pedersen H, Knutson K, Rydholm U: Percutaneous ankle arthrodesis
in the rheumatoid patient without débridement of the joint. Foot 1998,
8(4):226–229.
29. De Palma L, Santucci A, Verdenelli A, Paladini P, Ventura A: Arthroscopic
arthrodesis of the ankle in rheumatoid patients. Foot Ankle Surg 2000,
6(4):261–266.
30. Guyatt G, Oxman AD, Sultan S, Brozek J, Glasziou P, Alonso-Coello P, Atkins
D, Kunz R, Montori V, Jaeschke R, et al: GRADE guidelines: 11. Making an
overall rating of confidence in effect estimates for a single outcome and
for all outcomes. J Clin Epidemiol 2013, 66(2):151–157.
31. Smith R, Wood PL: Arthrodesis of the ankle in the presence of a large
deformity in the coronal plane. J Bone Joint Surg Br 2007, 89(5):615–619.
32. SooHoo NF, Zingmond DS, Ko CY: Comparison of reoperation rates
following ankle arthrodesis and total ankle arthroplasty. J Bone Joint Surg
Am 2007, 89(10):2143–2149.
33. Saltzman CL, Mann RA, Ahrens JE, Amendola A, Anderson RB, Berlet GC,
Brodsky JW, Chou LB, Clanton TO, Deland JT, et al: Prospective controlled
trial of STAR total ankle replacement versus ankle fusion: initial results.
Foot Ankle Int 2009, 30(7):579–596.
34. Sowa DT, Krackow KA: Ankle fusion: a new technique of internal fixation
using a compression blade plate. Foot & ankle 1989, 9(5):232–240.
35. Nelissen RG, Doets HC, Valstar ER: Early migration of the tibial component
of the buechel-pappas total ankle prosthesis. Clin Orthop Relat Res 2006,
448:146–151.36. Button G, Pinney S: A meta-analysis of outcome rating scales in foot and
ankle surgery: is there a valid, reliable, and responsive system? Foot Ankle
Int 2004, 25(8):521–525.
37. Schutte BG, Louwerens JW: Short-term results of our first 49
Scandanavian total ankle replacements (STAR). Foot Ankle Int 2008,
29(2):124–127.
38. Ergina PL, Cook JA, Blazeby JM, Boutron I, Clavien PA, Reeves BC, Seiler CM,
Balliol C, Altman DG, Aronson JK, et al: Challenges in evaluating surgical
innovation. Lancet 2009, 374(9695):1097–1104.
39. Coster M, Karlsson MK, Nilsson JA, Carlsson A: Validity, reliability, and
responsiveness of a self-reported foot and ankle score (SEFAS). Acta
orthopaedica 2012, 83(2):197–203.
40. Dawson J, Boller I, Doll H, Lavis G, Sharp R, Cooke P, Jenkinson C:
Responsiveness of the Manchester-Oxford foot questionnaire (MOXFQ)
compared with AOFAS, SF-36 and EQ-5D assessments following foot or
ankle surgery. J Bone Joint Surg Br 2012, 94(2):215–221.
doi:10.1186/1471-2474-14-306
Cite this article as: van Heiningen et al.: The mid-term outcome of total
ankle arthroplasty and ankle fusion in rheumatoid arthritis: a systematic
review. BMC Musculoskeletal Disorders 2013 14:306.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
